Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: A study of 125 Japanese pediatric cases

International Journal of Hematology

Volumn 67, Issue 4, 1998, Pages 379-387

  Yokota, Shouhei ^a   Nakao, Makoto ^a   Horiike, Shigeo ^a   Seriu, Taku ^a   Iwai, Toshiki ^a   Kaneko, Hiroto ^a   Azuma, Hiroshi ^b   Oka, Toshiaki ^c   Takeda, Takeo ^d   Watanabe, Arata ^e   Kikuta, Atsushi ^f   Asami, Keiko ^g   Sekine, Isao ^h   Matsushita, Takeji ⁱ   Tsuhciya, Takayoshi ^j   Mimaya, Junichi ^k   Koizumi, Shoichi ^l   Miyake, Munenori ^m   Nishikawa, Kenichi ⁿ   Takaue, Yoichi ^o   Kawano, Yoshifumi ^o   Iwai, Asayuki ^p   Ishida, Yasushi ^q   Matsumoto, Kazuhiro ^r   Kawakami, Kiyoshi ^s   Hyakuna, Nobuyuki ^t   Tsurusawa, Masahito ^u   Fujimoto, Takeo ^u   more..

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c Department of Dental and Oral Surgery   (Japan)

^d HOKKAIDO CANCER CENTER   (Japan)

^e AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g NIIGATA CANCER CENTER HOSPITAL   (Japan)

^h NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁱ NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^j DOKKYO MEDICAL UNIVERSITY   (Japan)

^k SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^l KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^m OSAKA MEDICAL COLLEGE   (Japan)

ⁿ TOTTORI UNIVERSITY   (Japan)

^o UNIVERSITY OF TOKUSHIMA   (Japan)

^p National Hospital Organization   (Japan)

^q EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s KAGOSHIMA UNIVERSITY   (Japan)

^t UNIVERSITY OF THE RYUKYUS   (Japan)

^u AICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

ALL; Childhood; Point mutation; Prognosis; Ras

Indexed keywords

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CODON; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; OCCUPATIONAL HAZARD; ONCOGENE RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL RATE;

EID: 0031870590     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00015-2     Document Type: Article

References (37)

1. Barbacid M. ras Genes. Annu Rev Biochem. 56:1987;779-827.
2. Bos J.L. ras Oncogenes in human cancer: a review. Cancer Res. 49(17):1989;4682-4689.
3. Needleman S.W., Kraus M.H., Srivastava S.K., Levine P.H., Aaronson S.A. High frequency of N-ras activation in acute myelogenous leukemia. Blood. 67(3):1986;753-757.
4. Bos J.L., Toksoz D., Marshall C.J.et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature. 315(6022):1985;726-730.
5. Bos J.L., Verlaan-de Vries M., van der Eb A.J.et al. Mutations in N-ras predominate in acute myeloid leukemia. Blood. 69(4):1987;1237-1241.
6. Toksoz D., Farr C.J., Marshall C.J. ras Gene activation in a minor proportion of the blast population in acute myeloid leukemia. Oncogene. 1(4):1987;409-413.
7. Janssen J.W., Steenvoorden A.C., Lyons J.et al. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA. 84(24):1987;9228-9232.
8. Senn H.P., Tran-Thang C., Wodnar-Filipowicz A.et al. Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias. Int J Cancer. 41(1):1988;59-64.
9. Bartram C.R., Ludwig W.D., Hiddemann W.et al. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia. 3(4):1989;247-256.
10. Ahuja H.G., Foti A., Bar-Eli M., Cline M.J. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood. 75(8):1990;1684-1690.
11. Rodenhuis S., Bos J.L., Slater R.M., Behrendt H., van 't Veer M., Smets L.A. Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood. 67(6):1986;1698-1704.
12. Neri A., Knowles D.M., Greco A., McCormick F., Dalla-Favera R. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA. 85(23):1988;9268-9272.
13. Bar-Eli M., Ahuja H., Foti A., Cline M.J. N-ras mutations in T-cell acute lymphocytic leukaemia: analysis by direct sequencing detects a novel mutation. Br J Haematol. 72(1):1989;36-39.
14. Lubbert M., Mirro J. Jr., Miller C.W.et al. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood. 75(5):1990;1163-1169.
15. Terada N., Miyoshi J., Kawa-Ha K.et al. Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia. Blood. 75(2):1990;453-457.
16. Hirai H., Kobayashi Y., Mano H.et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature. 327(6121):1987;430-432.
17. Padua R.A., Carter G., Hughes D.et al. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia. 2(8):1988;503-510.
18. Yunis J.J., Boot A.J.M., Mayer M.G., Bos J.L. Mechanism of ras mutation in myelodysplastic syndrome. Oncogene. 4(5):1989;609-614.
19. Horiike S., Misawa S., Nakai H.et al. N/ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome. Leukemia. 8(8):1994;1331-1336.
20. Paquette R.L., Berenson J., Lichtenstein A., McCormick F., Koeffler H.P. Oncogenes in multiple myeloma: point mutation of N-ras. Oncogene. 5(11):1990;1659-1663.
21. Portier M., Moles J.P., Mazars G.R.et al. p53 and RAS gene mutations in multiple myeloma. Oncogene. 7(12):1992;2539-2543.
22. Steenvoorden A.C., Janssen J.W., Drexler H.G.et al. Ras mutations in Hodgkin's disease. Leukemia. 2(5):1988;325-326. [Letter].
23. Trumper L., Pfreundschuh M., Jacobs G.et al. N/ras genes are not mutated in Hodgkin and Reed-Sternberg cells: results from single cell polymerase chain-reaction examinations. Leukemia. 10(4):1996;727-730.
24. Clark H.M., Yano T., Sander C., Jaffe E.S., Raffeld M. Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma. Leukemia. 10(5):1996;844-847.
25. Bennett J.M., Catovsky D., Daniel M.T.et al. The morphological classification of acute lymphoblastic leukemia; concordance among observers and clinical correlations. Br J Haematol. 47(4):1981;553-561.
26. Koizumi S., Fujimoto T., Takeda T.et al. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group. Cancer. 61(7):1988;1292-1300.
27. Koizumi S., Fujimoto T. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the Children's Cancer and Leukemia Study Group. Int J Hematol. 59:1994;99-112.
28. Nakao M., Yokota S., Kaneko H.et al. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage. Leukemia. 10(2):1996;249-254.
29. Todd A.V., Ireland C.M., Radloff T.J.et al. Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis. Am J Hematol. 38:1991;207-213.
30. Sandler D.P., Collman G.W. Cytogenetic and environmental factors in the etiology of the acute leukemias in adults. Am J Epidemiol. 126:1987;1017-1032.
31. Rivera GK, Kalwinsky DK, Rodman J, et al. Current approaches to therapy for childhood lymphoblastic leukemia: St Jude studies XI (1984-1988) and XII (1988). In: Modern Trends in Human Leukemia, vol VIII. New York, NY: Springer, 1990.
32. Koizumi S., Fujimoto T. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by The Children's Cancer and Leukemia Study Group. Int J Hematol. 59(2):1994;99-112.
33. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54(18):1994;4855-4878.
34. Horsfall M.J., Gordon A.J., Burns P.A., Zielenska M., van der Vliet G.M., Glickman B.W. Mutational specificity of alkylating agents and the influence of DNA repair. Environ Mol Mutagen. 15(2):1990;107-122.
35. Zarbl H., Sukumar S., Arthur A.V., Martin-Zanca D., Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N- methylurea during initiation of mammary carcinogenesis in rats. Nature. 315(6018):1985;382-385.
36. Lowengart R.A., Peters J.M., Cicioni C.et al. Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst. 79(1):1987;39-46.
37. Taylor J.A., Sandler D.P., Bloomfield C.D.et al. ras Oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst. 84(21):1992;1626-1632.